Colitis, Ulcerative Clinical Trials in San Antonio, Texas

7 studies are recruiting for colitis, ulcerative in San Antonio, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

   Researchers want to learn more about tulisokibart (also known as MK-7240) in an extension study. Tulisokibart is a medicine designed to treat active, moderate to severe Crohn's disease (CD) and ulcerative colitis (UC). An extension study is a type of study where people who received tulisokibart in …

   Stage

   Phase 3

   Ages

   Any age

   Site

   Southern Star Research Institute ( Site 0299), San Antonio, Texas

   Locations

   37 in total

   Run by

   Merck Sharp & Dohme LLC

   See if you can join NCT06651281 on ClinicalTrials.gov

2. Confirmatory Clinical Study in Active Ulcerative Colitis

   The main goal of the study is to check if MH002 works and is safe to use. In a previous study in 45 patients with Ulcerative Colitis, MH002 was found to have favorable effects. In this study, 2 different doses will be tested, and long-term treatment effects will be investigated. MH002 is a live bio…

   Stage

   Phase 2

   Ages

   16 and older

   Site

   Southern Star Research Institute, San Antonio, Texas

   Locations

   25 in total

   Run by

   MRM Health NV

   See if you can join NCT07296315 on ClinicalTrials.gov

3. A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

   Study IIBD is a master protocol that will support a collection of individual sub studies that share key design components. Participants will be assigned to the appropriate study prior to randomization to a treatment group. The studies aim to evaluate the efficacy and safety of new treatments in adu…

   Stage

   Phase 2

   Ages

   18 to 80

   Site

   Southern Star Research Institute, San Antonio, Texas

   Locations

   70 in total

   Run by

   Eli Lilly and Company

   See if you can join NCT07483073 on ClinicalTrials.gov

4. A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

   The purpose of this protocol is to evaluate the efficacy (how well it works), safety and tolerability of oral icotrokinra as therapy in adult and adolescent participants with moderately to severely active ulcerative colitis (UC, a chronic disease of the large intestine in which the lining of the co…

   Stage

   Phase 3

   Ages

   12 and older

   Site

   Southern Star Research Institute, LLC, San Antonio, Texas

   Locations

   401 in total

   Run by

   Janssen Research & Development, LLC

   See if you can join NCT07196748 on ClinicalTrials.gov

5. A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

   The purpose of this study is to assess how well JNJ-78934804 works (efficacy) and how safe it is (safety) as compared to guselkumab at Week 48 in participants with moderately to severely active ulcerative colitis (UC, a chronic disease of the large intestine in which the lining of the colon becomes…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Southern Star Research Institute, LLC, San Antonio, Texas

   Locations

   170 in total

   Run by

   Janssen Research & Development, LLC

   See if you can join NCT07577856 on ClinicalTrials.gov

6. A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

   This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active ulcerative colitis (UC). The primary goal of the study is to assess the efficacy and safety of multiple interventions following intravenous (IV) induction and subcutaneous (SC) m…

   Stage

   Phase 2

   Ages

   18 to 75

   Site

   Site 002, San Antonio, Texas

   Locations

   267 in total

   Run by

   Spyre Therapeutics, Inc.

   See if you can join NCT07012395 on ClinicalTrials.gov

7. An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

   The purpose of this observational study is to learn about the effects of etrasimod as a treatment for adult patients with moderate to severe ulcerative colitis. Patients will be treated according to standard of care and will only be included in the study if etrasimod is the best treatment of choice…

   Stage

   Not phased

   Ages

   18 to 64

   Site

   Brooke Army Medical center, San Antonio, Texas

   Locations

   28 in total

   Run by

   Pfizer

   See if you can join NCT06398626 on ClinicalTrials.gov